Peter S Roddy - Net Worth and Insider Trading
Peter S Roddy Net Worth
The estimated net worth of Peter S Roddy is at least $170,059 dollars as of 2024-04-26. Peter S Roddy is the CFO of Cassava Sciences Inc and owns about 7,826 shares of Cassava Sciences Inc (SAVA) stock worth over $170,059. Details can be seen in Peter S Roddy's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Peter S Roddy has not made any transactions after 2009-08-31 and currently still holds the listed stock(s).
Transaction Summary of Peter S Roddy
Peter S Roddy Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Peter S Roddy owns 3 companies in total, including Cytokinetics Inc (CYTK) , Cassava Sciences Inc (SAVA) , and Aspira Womens Health Inc (AWH) .
Click here to see the complete history of Peter S Roddy’s form 4 insider trades.
Insider Ownership Summary of Peter S Roddy
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CYTK | Cytokinetics Inc | 2018-02-08 | SVP Finance & CAO |
| SAVA | Cassava Sciences Inc | 2009-08-31 | Chief Financial Officer |
| AWH | Aspira Womens Health Inc | 2010-02-18 | director |
Peter S Roddy Latest Holdings Summary
Peter S Roddy currently owns a total of 1 stock. Peter S Roddy owns 7,826 shares of Cassava Sciences Inc (SAVA) as of August 31, 2009, with a value of $170,059.
Latest Holdings of Peter S Roddy
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SAVA | Cassava Sciences Inc | 2009-08-31 | 7,826 | 21.73 | 170,059 |
Holding Weightings of Peter S Roddy
Peter S Roddy Form 4 Trading Tracker
According to the SEC Form 4 filings, Peter S Roddy has made a total of 0 transactions in Cassava Sciences Inc (SAVA) over the past 5 years. The most-recent trade in Cassava Sciences Inc is the sale of 5,714 shares on August 31, 2009, which brought Peter S Roddy around $203,200.
Insider Trading History of Peter S Roddy
- 1
Peter S Roddy Trading Performance
GuruFocus tracks the stock performance after each of Peter S Roddy's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Peter S Roddy is 8.17%. GuruFocus also compares Peter S Roddy's trading performance to market benchmark return within the same time period. The performance of stocks bought by Peter S Roddy within 3 months outperforms 2 times out of 6 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Peter S Roddy's insider trading performs compared to the benchmark.
Performance of Peter S Roddy
Average Return
-5.07%
Outperforming Transactions
33%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 7.01 | 8.17 | 8.31 | -5.07 | 14.04 | 2.2 |
| Relative Return to S&P 500(%) | 4.35 | 6.65 | 7.55 | -11 | 5.44 | -0.75 |
Peter S Roddy Ownership Network
Ownership Network List of Peter S Roddy
Ownership Network Relation of Peter S Roddy
Peter S Roddy Owned Company Details
What does Cytokinetics Inc do?
Who are the key executives at Cytokinetics Inc?
Peter S Roddy is the SVP Finance & CAO of Cytokinetics Inc. Other key executives at Cytokinetics Inc include SVP Research & Early Dev Fady Ibraham Malik , EVP & Corp. Development & CBO Robert I Blum , and VP & Chief Accounting Officer Robert Wong .
Cytokinetics Inc (CYTK) Insider Trades Summary
Over the past 18 months, Peter S Roddy made no insider transaction in Cytokinetics Inc (CYTK). Other recent insider transactions involving Cytokinetics Inc (CYTK) include a net sale of 322,500 shares made by Robert I Blum , a net sale of 135,675 shares made by Fady Ibraham Malik , and a net sale of 27,186 shares made by John T Henderson .
In summary, during the past 3 months, insiders sold 93,272 shares of Cytokinetics Inc (CYTK) in total and bought 0 shares, with a net sale of 93,272 shares. During the past 18 months, 532,719 shares of Cytokinetics Inc (CYTK) were sold and 0 shares were bought by its insiders, resulting in a net sale of 532,719 shares.
Cytokinetics Inc (CYTK)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cytokinetics Inc Insider Transactions
Peter S Roddy Mailing Address
Above is the net worth, insider trading, and ownership report for Peter S Roddy. Currently GuruFocus does not have mailing address information for Peter S Roddy.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
